Savara (SVRA) Other Non-Current Assets (2010 - 2026)
Savara's (SVRA) quarterly Other Non-Current Assets came in at $11.4 million in Q1 2026, up 5.88% year-on-year from $10.7 million in Q1 2025, and down 2.34% on a QoQ basis from $11.6 million in Q4 2025.
Savara (SVRA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Other Non-Current Assets data on file, last reported at $11.4 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 5.88% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $11.4 million, a 5.88% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 12.97% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $11.4 million, down from $11.6 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for SVRA reached as high as $11.6 million in Q4 2025 and fell as low as $116000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $8.4 million across 5 years, with a median of $10.7 million in 2024.
- Across the five-year window, Other Non-Current Assets plunged 98.97% in 2022 and soared 2561.5% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $116000.0 in 2022, then soared by 233.62% to $387000.0 in 2023, then surged by 2561.5% to $10.3 million in 2024, then gained by 12.97% to $11.6 million in 2025, then retreated by 2.34% to $11.4 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $11.4 million in Q1 2026, $11.6 million in Q4 2025, and $990000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 11.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.36 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Sep 30, 2025 | 990,000.00 |
| Jun 30, 2025 | 11.63 Mn |
| Mar 31, 2025 | 10.73 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 11.11 Mn |
| Jun 30, 2024 | 10.63 Mn |
| Mar 31, 2024 | 10.71 Mn |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 10.50 Mn |
| Jun 30, 2023 | 10.78 Mn |
| Mar 31, 2023 | 10.82 Mn |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 9.75 Mn |
| Jun 30, 2022 | 952,000.00 |
| Mar 31, 2022 | 11.06 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 11.83 Mn |